12 Information Technology Stocks Moving In Thursday’s Pre-Market Session

Gainers Blackboxstocks (NASDAQ:BLBX) shares moved upwards by 45.1% to $4.7 during Thursday’s pre-market session. The company’s market cap…

Gainers

  • Blackboxstocks (NASDAQ:BLBX) shares moved upwards by 45.1% to $4.7 during Thursday’s pre-market session. The company’s market cap stands at $15.1 million.
  • Minim (NASDAQ:MINM) stock increased by 15.85% to $4.75. The market value of their outstanding shares is at $13.7 million.
  • Akoustis Technologies (NASDAQ:AKTS) stock rose 11.59% to $0.64. The market value of their outstanding shares is at $63.1 million.
  • Edgio (NASDAQ:EGIO) stock moved upwards by 8.07% to $0.28. The market value of their outstanding shares is at $65.8 million.
  • Cheetah Mobile (NYSE:CMCM) shares rose 7.28% to $2.21. The company’s market cap stands at $66.1 million.
  • Qorvo (NASDAQ:QRVO) shares moved upwards by 6.27% to $106.0. The market value of their outstanding shares is at $10.3 billion. The company’s, Q3 earnings came out yesterday.

Losers

  • Infobird Co (NASDAQ:IFBD) shares fell 28.7% to $0.97 during Thursday’s pre-market session. The company’s market cap stands at $7.2 million.
  • Addvantage Technologies (NASDAQ:AEY) shares fell 16.22% to $1.55. The company’s market cap stands at $2.3 million.
  • Cemtrex (NASDAQ:CETX) stock declined by 12.2% to $3.6. The market value of their outstanding shares is at $3.8 million.
  • MaxLinear (NASDAQ:MXL) stock declined by 11.39% to $18.45. The company’s market cap stands at $1.5 billion. As per the press release, Q4 earnings came out yesterday.
  • CCSC Technology (NASDAQ:CCTG) shares decreased by 10.34% to $19.0. The market value of their outstanding shares is at $216.1 million.
  • Remark Hldgs (NASDAQ:MARK) shares fell 9.07% to $0.59. The company’s market cap stands at $12.2 million.
    See Also: www.benzinga.com/money/tech-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Why Palisade Bio Stock Is Up Today

Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative colitis (UC) therapy and provides the company access to advanced bioinformatics tools vital for understanding complex disease pathways and predicting responses to PDE4 inhibitors. 

PALI